Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 13.50
High: 13.50
Low: 13.50
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update for the quarter ended 30 September 2018

23 Nov 2018 07:00

RNS Number : 2789I
Seneca Growth Capital VCT PLC
23 November 2018
 

Seneca Growth Capital VCT Plc (the "Company")

Update for the quarter ended 30 September 2018

The Company presents its quarterly update for the period from 1 July 2018 to 30 September 2018.

The Directors have recently reviewed the valuation of its portfolio as at the quarter ended 30 September 2018.

The unaudited net asset value per share ("NAV") of an Ordinary Share as at 30 September 2018 was 60.4p. This is a decrease of 1.9p from the previously published NAV for the period ended 30 June 2018, due to changes in the value of the quoted investments. No changes have been made to the unquoted valuations. The ordinary running costs of the Company (limited by the Cost Cap) have been absorbed by the New "B" Share class as set out in the prospectus for the current offer for subscription for those shares (the "Prospectus").

The unaudited NAV of a New "B" Share as at 30 September 2018 was 99.7p. This is a decrease of 0.3p from the initial offer price of 100p, due to running costs incurred in the quarter. The decrease is limited by the impact of the Cost Cap which restricts the burden of ordinary running costs on the New "B" Share class to 3% of the NAV of the New "B" Shares on an annualised basis ("the Cost Cap").

On 23 August 2018 and 27 September 2018, the Company made two allotments, issuing a total of 3,461,786 New "B" Shares. In accordance with the allotment formula set out in the Prospectus, the offer prices at which the New "B" Shares were issued were in the range of 100p to 105.8p per share.

Following the initial allotment on 23 August 2018, the Company repaid its £200,000 bank loan with RBS and the debenture in relation to the loan has now been released. The payment created an inter share class balance between the Ordinary Shares and the New "B" Shares which will be repaid from the next realisations from the Ordinary Share investments.

James Cowper Kreston, our auditors for the last 8 years, have decided to withdraw from auditing Public Interest Entities for the time being due to the increasing regulatory landscape and associated costs. Unfortunately this includes VCTs. The Board would like to thank them for all their support and constructive feedback during their period in office. The Company has therefore carried out a tender process, and the Board, on the recommendation of the Audit Committee, has agreed to appoint UHY Hacker Young LLP ("UHY") to fill the casual vacancy that has arisen. UHY will audit the Company's 2018 annual results for the year ending 31 December 2018, and shareholders will be asked to reappoint them at next year's AGM for the following year's audit.

The Directors are not aware of any other events or transactions which have taken place between 1 October 2018 and the publication of this statement which have had a material effect on the financial position of the Company.

Furthermore, for the purposes of DTR 5.6.1 of the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules, the total number of shares in the Company in issue as at close of business on 1 October 2018 was 8,115,376 Ordinary Shares and 3,461,786 New "B" Shares each with a nominal value of 1p each. The Company does not hold any Ordinary Shares nor New "B" Shares in treasury. Therefore, the total number of voting rights in the Company is 11,577,162 (the 'Figure').The Figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's shares under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

 

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

 

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

 

Any enquiries regarding the offer for subscription of New "B" Shares should be directed to:

 

John Davies at Seneca Partners Limited on 01942 295 981 or at John.Davies@senecapartners.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDVLLFLVFFLFBB
Date   Source Headline
31st Mar 20205:30 pmGNWNet Asset Value(s)
26th Mar 20204:31 pmGNWAGM Venue Change
13th Mar 20204:14 pmGNWInterim Dividend
10th Mar 20202:28 pmGNWIssue of Equity
10th Mar 20207:00 amGNWB Share Net Asset Value
3rd Mar 20204:30 pmGNWIssue of Supplementary Prospectus
27th Feb 20207:00 amGNWFinal Results
9th Dec 20195:45 pmGNWDirectorate Change
27th Nov 20192:45 pmGNWIssue of Equity
20th Nov 20194:00 pmGNWDuplicate: Second Interim Dividend
28th Oct 20197:00 amGNWSecond interim dividend
10th Oct 20196:30 pmGNWDirector/PDMR Shareholding
8th Oct 20191:55 pmGNWIssue of Equity
8th Oct 20197:00 amGNWUpdate for the quarter ended 30 September 2019
17th Jul 20198:00 amGNWCorrection: Offer for Subscription
16th Jul 20195:27 pmGNWOffer for Subscription
10th Jul 20195:20 pmGNWHalf-year report
18th Jun 20199:16 amRNSHolding(s) in Company
10th Jun 20196:14 pmRNSResult of AGM
16th May 20197:00 amRNSSecond Interim Dividend
29th Apr 20198:52 amRNSFinal Results
25th Apr 20197:00 amRNSNet Asset Value(s)
5th Apr 201912:47 pmRNSIssue of Equity
3rd Apr 201912:46 pmRNSIssue of Equity
29th Mar 20195:20 pmRNSRevised timetable
13th Mar 201912:03 pmRNSExtension of Offer
7th Mar 20193:22 pmRNSIssue of Equity
6th Mar 201910:30 amRNSInterim Dividend
6th Mar 20198:39 amRNSNet Asset Value(s)
28th Dec 20187:00 amRNSDividend Declaration
19th Dec 20182:21 pmRNSIssue of Equity
18th Dec 20189:56 amRNSUpdate on Hallmarq
17th Dec 20184:43 pmRNSReduction of Capital
29th Nov 20181:53 pmRNSHolding(s) in Company
23rd Nov 20187:00 amRNSUpdate for the quarter ended 30 September 2018
27th Sep 201810:59 amRNSIssue of Equity
23rd Apr 201812:43 pmRNSHolding(s) in Company
22nd May 201712:59 pmRNSHolding(s) in Company
24th Feb 201610:42 amRNSScancell to present at Biotech Capital
16th Feb 20159:47 amRNSHoldings in Company
24th Oct 20133:53 pmRNSInterim Management Statement
22nd Mar 20127:00 amRNSFinal Results
29th Oct 201011:18 amRNSInterim Management Statement
7th Sep 201011:34 amRNSDirector's Dealings
5th Aug 20107:00 amRNSHalf Yearly Report
7th May 20107:00 amRNSResults of AGM and IMS to 31 March 2010
31st Mar 20104:48 pmRNSAnnual Financial Report
22nd Jan 201012:26 pmRNSDeclaration of Interim Dividend
24th Sep 20099:43 amRNSDirector's Dealing
22nd Sep 200910:10 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.